Table 1.
LI status at subsequent biopsy | ||||
---|---|---|---|---|
0–25 % TDLU (N = 92) (%) | 26–50 % TDLU (N = 238) (%) | 51–75 % TDLU (N = 317) (%) | >75 % TDLU (N = 468) (%) | |
LI status at initial biopsy | ||||
0–25 % TDLU | 77 (83.7) | 84 (35.3) | 75 (23.7) | 64 (13.7) |
26–50 % TDLU | 9 (9.8) | 95 (39.9) | 100 (31.5) | 82 (17.5) |
51–75 % TDLU | 3 (3.3) | 41 (17.2) | 102 (32.2) | 102 (21.8) |
>75 % TDLU | 3 (3.3) | 18 (7.6) | 40 (12.6) | 220 (47.0) |
Women categorized as LI progression (N = 507) are colored blue, women categorized as LI stasis (N‐327) are colored red, and women with complete involution (>75 %) at initial biopsy were excluded from consideration as LI progression versus stasis